Wird geladen...
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
BACKGROUND: We sought to develop and validate clinically relevant, early assessment continuous tumor measurement–based metrics for predicting overall survival (OS) using the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 data warehouse. METHODS: Data from 13 trials representing 2096 patie...
Gespeichert in:
| Veröffentlicht in: | J Natl Cancer Inst |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643633/ https://ncbi.nlm.nih.gov/pubmed/26296640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv239 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|